In vitro analysis of the activity of human monoamine oxidase type B (hMAOB), treated with the cyanotoxin anatoxin-a: supposed factor of neurodegenerative diseases
Authors/Creators
- 1. Medical University of Sofia, Sofia, Bulgaria
- 2. National Center of Public Health and Analyses, Sofia, Bulgaria
Description
In this study, we investigated the hypothesis that an additional source of free radicals may be hydrogen peroxide formed by monoamino oxidase (MAO) -catalyzed deamination of catecholamines. Also, increased MAO-B activity in the brain has been linked to the development of some neurodegenerative diseases.
The toxicant we used to treat recombinant human MAO-B enzyme is the cyanotoxin аnatoxin-a. For anatoxin-a is known that it's an agonist of neuronal acetylcholine receptors with 20 times greater affinity to them compared to the natural neurotransmitter.
In this study, we analyzed the effect of anatoxin at various selected concentrations on the activity of recombinant human MAO-B enzyme. The method we use is to analyze the activity of human MAO-B with the fluorimetric reagent Amplex UltraRed and the substrate tyramine hydrochloride.
The aim of this study is to analyze the effect of anatoxin-a on the hMAO-B enzyme activity and its influence as a factor for the development and progression of neurodegenerative diseases.
Files
PHAR_article_50806.pdf
Files
(296.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:1b6d0d26e034e62f26b0e754397599bc
|
264.4 kB | Preview Download |
|
md5:a48c45227cb3f48432fbb11dd09eeca0
|
32.4 kB | Preview Download |
Additional details
Related works
- Has part
- Figure: 10.3897/pharmacia.67.e50806.figure1 (DOI)
- Figure: 10.3897/pharmacia.67.e50806.figure2 (DOI)